Tag: prostate cancer

The title is a bit of a trick question. MRI can’t “see” actual genes or prostate cancer gene mutations. There are indeed genetic factors that contribute to both the risk of developing prostate cancer (PCa), and the behavior of particular cell lines. Ongoing research continues to shed light on the genomics of prostate cancer, and keep reading

If there were an accurate crystal ball, would you want to know your future? And if you knew something bad was going to happen, would you try to take steps to avoid it? The ancient Greek notion that you can’t escape your fate is illustrated by the tragic tale of King Oedipus, who was informed keep reading

If you know about metformin, a drug that is the “main first-line oral drug of choice” for type 2 diabetes patients of all agesi, you may be wondering, “Why is Dr. Sperling writing about something that has nothing to do with prostate cancer?” In fact, metformin DOES apply to prostate cancer... keep reading

Prostate cancer (PCa) is not a basic yes/no diagnosis. It would be so easy to say, “You either have it or you don’t.” If that were the case, treatment decisions would be simplified. Instead, PCa can be seen as a spectrum of diseases from precancerous conditions that can become full blown cancer, all the way keep reading

For over 75 years, testosterone replacement therapy (TRT) has been a big no-no for prostate cancer (PCa) patients. It’s unfortunate, because as men age, it’s not unusual for testosterone levels to drop, often leading to low libido, loss of muscle tone, weight gain, fatigue, and even mental/emotional changes such as depression. While PCa survivors with keep reading

The bold tag line for University College London (UCL) is “Disruptive thinking since 1826.” Back in 1826, when this global university was founded, the phrase disruptive thinking did not even exist! Today, the term disruptive permeates the worlds of industry, businesses, technology and research. Not only do disruptive innovations alter the way these fields operate, keep reading

Few medical centers are as venerable as the Mayo Clinic. It began when William Worrall Mayo, a physician and chemist, settled his family on the Minnesota prairie in 1864, and opened a small practice. His two doctor sons joined the practice. As other partners came on board, it grew into the Mayo Clinic. Today, its keep reading

These days, Active Surveillance (AS) seems to be the new best friend for prostate cancer (PCa) patients. Over 40% of newly diagnosed, low-to-favorable intermediate risk patients now begin PCa management on AS. This method defers treatment, but there’s a catch. Patients must be responsible to: Obtain the most thorough portrait of your PCa (multiparametric MRI, keep reading

What do these terms have in common? ✓ Sexual adjustment ✓ Masculine self-esteem ✓ Unmet sexual supportive care needs Chances are, prostate cancer (PCa) patients treated with radical prostatectomy (RP) will discover that those terms, and others, commonly apply after their surgery. For some, such challenges are resolved within 6-12 months after treatment. For others, keep reading

When something is described as cost-effective, what does that mean? According to the Merriam Webster Dictionary, it indicates the thing or action produces good results without costing a lot of money. There is no question that multiparametric MRI (mpMRI) of the prostate, performed on a high-power 3T magnet, produces good results. In fact, when interpreted keep reading